Weybosset Research & Management LLC Sells 1,969 Shares of Colgate-Palmolive (NYSE:CL)

Weybosset Research & Management LLC decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.9% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 66,960 shares of the company’s stock after selling 1,969 shares during the period. Colgate-Palmolive comprises approximately 2.4% of Weybosset Research & Management LLC’s holdings, making the stock its 20th largest position. Weybosset Research & Management LLC’s holdings in Colgate-Palmolive were worth $4,610,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Retirement Income Solutions Inc grew its position in Colgate-Palmolive by 5.5% during the third quarter. Retirement Income Solutions Inc now owns 10,067 shares of the company’s stock valued at $740,000 after buying an additional 524 shares during the period. Schulhoff & Co. Inc. bought a new position in Colgate-Palmolive during the third quarter valued at about $406,000. Rehmann Capital Advisory Group grew its position in Colgate-Palmolive by 11.1% during the second quarter. Rehmann Capital Advisory Group now owns 3,160 shares of the company’s stock valued at $227,000 after buying an additional 315 shares during the period. Douglass Winthrop Advisors LLC grew its position in Colgate-Palmolive by 16.0% during the third quarter. Douglass Winthrop Advisors LLC now owns 12,142 shares of the company’s stock valued at $893,000 after buying an additional 1,674 shares during the period. Finally, BlackRock Inc. grew its position in Colgate-Palmolive by 0.5% during the second quarter. BlackRock Inc. now owns 60,205,815 shares of the company’s stock valued at $4,314,949,000 after buying an additional 279,887 shares during the period. Hedge funds and other institutional investors own 76.68% of the company’s stock.

In other Colgate-Palmolive news, Chairman Ian M. Cook sold 19,500 shares of the stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $70.73, for a total value of $1,379,235.00. Following the sale, the chairman now owns 1,044,361 shares in the company, valued at $73,867,653.53. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Chairman Ian M. Cook sold 16,000 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $66.73, for a total value of $1,067,680.00. The disclosure for this sale can be found here. Insiders sold 87,000 shares of company stock valued at $5,948,528 over the last 90 days. 1.14% of the stock is owned by company insiders.

Several research firms recently weighed in on CL. Bank of America lowered shares of Colgate-Palmolive from a “buy” rating to a “neutral” rating and reduced their price target for the company from $77.00 to $74.00 in a research report on Thursday, December 19th. Morgan Stanley set a $71.00 price target on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $78.00 to $76.00 and set a “neutral” rating for the company in a research report on Monday, October 14th. ValuEngine upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Thursday, November 14th. Finally, Deutsche Bank increased their target price on shares of Colgate-Palmolive from $72.00 to $73.00 and gave the stock a “hold” rating in a research report on Thursday, December 12th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company. Colgate-Palmolive currently has an average rating of “Hold” and an average price target of $73.36.

Shares of CL stock traded up $0.12 during trading hours on Monday, reaching $70.42. The stock had a trading volume of 1,696,089 shares, compared to its average volume of 3,326,977. The stock’s fifty day simple moving average is $69.15 and its 200 day simple moving average is $70.28. The company has a current ratio of 1.03, a quick ratio of 0.70 and a debt-to-equity ratio of 43.94. Colgate-Palmolive has a 12 month low of $60.96 and a 12 month high of $76.41. The firm has a market capitalization of $60.25 billion, a PE ratio of 26.08, a PEG ratio of 5.43 and a beta of 0.71.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, November 1st. The company reported $0.71 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.01. Colgate-Palmolive had a net margin of 15.04% and a return on equity of 6,492.71%. The company had revenue of $3.93 billion during the quarter, compared to analyst estimates of $3.95 billion. During the same period last year, the business earned $0.72 earnings per share. Colgate-Palmolive’s revenue was up 2.2% compared to the same quarter last year. As a group, equities research analysts anticipate that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Thursday, January 23rd will be given a $0.43 dividend. The ex-dividend date of this dividend is Wednesday, January 22nd. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.44%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.91%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Further Reading: Differences Between Momentum Investing and Long Term Investing

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.